HOTHHoth Therapeutics, Inc.

Nasdaq hoththerapeutics.com


$ 0.72 $ -0.03 (-4.61 %)    

Tuesday, 20-Aug-2024 09:37:45 EDT
QQQ $ 479.92 $ -1.38 (-0.29 %)
DIA $ 408.31 $ -0.58 (-0.14 %)
SPY $ 558.13 $ -1.03 (-0.18 %)
TLT $ 98.57 $ 0.27 (0.27 %)
GLD $ 232.13 $ -1.59 (-0.68 %)
$ 0.7548
$ 0.72
$ 0.69 x 102
$ 0.76 x 1,425
$ 0.72 - $ 0.72
$ 0.58 - $ 3.37
333,206
na
5.21M
$ 0.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-29-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-16-2021 12-31-2020 10-K
16 11-10-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-13-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 04-01-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-hoth-therapeutics-maintains-4-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $4 pr...

 hc-wainwright--co-reiterates-buy-on-hoth-therapeutics-maintains-4-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $4 pr...

Core News & Articles
Market-Moving News for July 24th
07/24/2024 12:34:15

TSLA: -8.8% | Tesla shares are trading lower following mixed Q2 earnings. The company also said it expects 2024 vehicle volume ...

 hc-wainwright--co-reiterates-buy-on-hoth-therapeutics-maintains-4-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $4 pr...

 hoth-therapeutics-approved-to-proceed-with-first-in-human-phase-2a-clinical-trial-of-ht-001-for-treatment-of-skin-toxicities-associated-with-epidermal-growth-factor-receptor-inhibitors

Three New Sites Join HT-001 Trial, GW University Hospital, UC Irvine and Northwell Health

 hoth-therapeutics-and-wise-systems-international-srl-announces-joint-development-to-utilize-artificial-intelligence-for-drug-discovery-nvidia-bionemo-generative-ai-platform-will-be-used-to-accelerate-the-training-of-models-on-proprietary-data

Nvidia BioNeMo generative AI platform will be used to accelerate the training of models on proprietary dataNEW YORK, June 10, 2...

 hc-wainwright--co-reiterates-buy-on-hoth-therapeutics-maintains-4-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $4 pr...

 ef-hutton-maintains-buy-on-hoth-therapeutics-raises-price-target-to-7

EF Hutton analyst Tim Moore maintains Hoth Therapeutics (NASDAQ:HOTH) with a Buy and raises the price target from $6.5 to $7.

 why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

 why-is-alzheimers-focused-hoth-therapeutics-stock-trading-higher-on-tuesday

Hoth Therapeutics reveals preclinical findings on HT-ALZ, a potential Alzheimer's therapeutic targeting the Substance P/Neu...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION